This is a routine board appointment with no immediate trading signal. Monitor for any future strategic moves or committee actions that may signal changes in governance or strategy, but no action warranted now.
Price Chart
Executive Summary
Alamar Biosciences appointed Robert Ragusa to its Board of Directors, effective September 1, 2026, as a Class I director with a term expiring at the 2027 Annual Meeting. He also joined the Audit, Compensation, and Nominating and Corporate Governance Committees. This is a routine board appointment with no material financial or strategic implications.
Key Facts
- Robert Ragusa appointed to the Board effective September 1, 2026
- Serves as Class I Director with term expiring at 2027 Annual Meeting
- Appointed to Audit, Compensation, and Nominating and Corporate Governance Committees
- Compensated under standard Non-Employee Director Compensation Policy
Financial Impact
No financial impact disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-378360 |
| Document: 0001193125-26-378360-index-headers.html | 0001193125-26-378360 |
| Document: 0001193125-26-378360-index.html | 0001193125-26-378360 |
| Document: 0001193125-26-378360.txt | 0001193125-26-378360 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 11d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers